The Current Ratio as of November 2024 (TTM) for Tiziana Life Sciences Ltd (TLSA) is 1.12

According to Tiziana Life Sciences Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 1.12. This represents a change of -47.93% compared to the average of 2.15 of the last 4 quarters.

Tiziana Life Sciences Ltd (TLSA) Historical Current Ratio (quarterly & annually)

How has TLSA Current Ratio performed in the past?

The mean historical Current Ratio of Tiziana Life Sciences Ltd over the last ten years is 4.07. The current 1.12 Current Ratio has changed 2.66% with respect to the historical average. Over the past ten years (40 quarters), TLSA's Current Ratio was at its highest in in the December 2015 quarter at 12.40. The Current Ratio was at its lowest in in the December 2010 quarter at 0.

Tiziana Life Sciences Ltd (TLSA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tiziana Life Sciences Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tiziana Life Sciences Ltd (TLSA) Average Current Ratio

How has TLSA Current Ratio performed in the past?

The current Current Ratio of Tiziana Life Sciences Ltd (TLSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tiziana Life Sciences Ltd (TLSA) Current Ratio vs. Peers

How is TLSA’s Current Ratio compared to its peers?

Tiziana Life Sciences Ltd’s Current Ratio is less than Clearmind Medicine Inc. (0), less than Hillstream BioPharma, Inc. (1.71), less than Coeptis Therapeutics, Inc. (2.25), greater than Magenta Therapeutics, Inc. (0.40), less than Quoin Pharmaceuticals, Ltd. (14.64), less than Affimed N.V. (3.02), less than Leap Therapeutics, Inc. (1.93), less than Adaptimmune Therapeutics plc (3.97), less than Corvus Pharmaceuticals, Inc. (3.85), greater than Aptose Biosciences Inc. (0.92), greater than Bionomics Limited (1.05), less than Accustem Sciences Inc. (3.30), greater than Comera Life Sciences Holdings, Inc. (0.12), greater than SciSparc Ltd. (0.90), less than Biohaven Pharmaceutical Holding Company Ltd. (4.10), less than Immunome, Inc. (2.89), less than Inhibrx Biosciences, Inc. (6.17), less than AgeX Therapeutics, Inc. (4.70), greater than Icosavax, Inc. (0.64), less than null (18.06),

Build a custom stock screener for Tiziana Life Sciences Ltd (TLSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tiziana Life Sciences Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tiziana Life Sciences Ltd (TLSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tiziana Life Sciences Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.